← Back to Search

Arm I (Telephone-based coaching session) for Lung Cancer

N/A
Recruiting
Led By Dan Raz
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age >= 65 years
Scheduled to undergo lung surgery for lung cancer or suspected lung cancer with curative intent (neoadjuvant therapy allowed)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 30, 60 and 180 days post discharge
Awards & highlights

Study Summary

This trial is comparing two methods for helping older adults who are having surgery for lung cancer and their caregivers improve their physical function. One method is telephone-based coaching for physical activity, and the other is self

Who is the study for?
This trial is for older adults scheduled for lung cancer surgery and their caregivers. It aims to see if phone coaching or self-monitoring can help maintain physical function during this time. Participants should be able to perform basic exercises and have access to a telephone.Check my eligibility
What is being tested?
The study tests two methods: one where participants receive regular phone calls from a coach who guides them through physical activities, and another where they monitor their own exercise routine without guidance.See study design
What are the potential side effects?
Since the interventions involve non-invasive techniques like exercise and educational support, side effects are minimal but may include typical exercise-related discomforts such as muscle soreness or fatigue.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 65 years old or older.
Select...
I am scheduled for lung surgery with the aim to cure lung cancer.
Select...
I am 18 years old or older.
Select...
I can read and understand English or Spanish and am willing to complete surveys about my health.
Select...
I have been diagnosed with lung cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 30, 60 and 180 days post discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 30, 60 and 180 days post discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Objective patient functional capacity
Secondary outcome measures
Caregiver reported quality of life
Functional capacity
Hospital readmissions
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (Telephone-based coaching session)Experimental Treatment6 Interventions
Patients attend telephone-based coaching sessions over 20-50 minutes once 7-14 days before standard of care surgery, and then at days 7, 14, 21, and 51 post-discharge, for a total of 5 sessions. Patients also receive a personalized physical activity program and set fitness goals. FCGs also receive coaching and serve as a walking buddy for their patient. Patients and FCGs also wear an activity monitor throughout the trial.
Group II: Arm II (Written education)Active Control5 Interventions
Patients receive written educational materials on physical activity and cancer survivorship. Patients and FCGs also wear an activity monitor throughout the trial.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,672 Previous Clinical Trials
40,926,059 Total Patients Enrolled
City of Hope Medical CenterLead Sponsor
567 Previous Clinical Trials
1,922,278 Total Patients Enrolled
Dan RazPrincipal InvestigatorCity of Hope Medical Center
3 Previous Clinical Trials
228 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of participants being admitted into this clinical study?

"Indeed, the information available on clinicaltrials.gov clearly indicates that this trial is actively seeking participants. The study was initially published on May 13th, 2024 and underwent its most recent update on December 28th, 2023. A total of 382 individuals are being enrolled in this research project at a single designated site."

Answered by AI

Are researchers currently seeking participants for this study?

"Indeed, as indicated on clinicaltrials.gov, this study is currently in the recruitment phase. The trial was initially posted on May 13th, 2024 and underwent its last update on December 28th, 2023. The research team aims to enroll a total of 382 patients from a single site."

Answered by AI
~255 spots leftby May 2028